Thoughts on the pathophysiology of nonallergic rhinitis

Current Allergy and Asthma Reports

Volumn 2, Issue 3, 2002, Pages 203-209

  Fokkens, Wytske J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allergic Rhinitis; Allergy Clin Immunol; Capsaicin; Nasal Mucosa; Rhinitis

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; INNERVATION; NERVOUS SYSTEM; NOSE; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; REVIEW; RHINITIS; VASCULARIZATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM; NOSE; RESPIRATORY MUCOSA; RHINITIS;

EID: 0036582822     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-002-0020-3     Document Type: Article

References (60)

1. International Rhinitis Management Working Group international consensus report on the diagnosis and management of rhinitis. Allergy 1994, 49(Suppl 19):1-34.
2. Dykewicz MS, Fineman S, Skoner DP, et al.: Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998, 81:478–518.
3. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334.
4. Slavin RG: Occupational rhinitis. Ann Allergy Asthma Immunol 1999, 83:597–601.
5. Sari-Minodier I, Charpin D, Signouret M, et al.: Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates. J Occup Environ Med 1999, 41:582–588.
6. Leroyer C, Malo JL, Girard D, et al.: Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med 1999, 56(5):334–338.
7. Shusterman D, Balmes J: Measurement of nasal irritant sensitivity to pulsed carbon dioxide: a pilot study. Arch Environ Health 1997, 52:334–340.
8. Mabry RL: Rhinitis of pregnancy. South Med J 1986, 79:965–971.
9. Settipane RA, Lieberman P: Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001, 86:494–507.
10. Jacobs RL, Freedman PM, Boswell RN: Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol 1981, 67:253–262.
11. Moneret-Vautrin DA, Hsieh V, Wayoff M, et al.: Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990, 64:513–518.
12. Ingels K, Durdurez JP, Cuvelier C, van Cauwenberge P: Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy 1997, 52:338–341.
13. Blom HM, Godthelp T, Fokkens WJ, et al.: The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739–747.
14. Numata T, Konno A, Hasegawa S, et al.: Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 1999, 119:304–313.
15. Sanico A, Togias A: Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol 1998, 12:65–72. This article describes possible mechanisms of idiopatic rhinitis with special emphasis on neural mechanisms.
16. Blom HM, Van Rijswijk JB, Garrelds IM, et al.: Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997, 27:796–801. The first and only study proving the effect of capsaicin in a double blind placebo controlled manner.
17. Gerth van Wijk R, Dieges PH: Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology 1994, 32:119–122.
18. Togias A, Lykens K, Kagey-Sobotka A, et al.: Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 1990, 141:1428–1433.
19. Braat JP, Mulder PG, Fokkens WJ, et al.: Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998, 157:1748–1755. Describes an objective, although a little enduring, way to prove idiopatic rhinitis.
20. Sanico AM, Philip G, Proud D, et al.: Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy 1998, 28:92–100.
21. Togias AG, Naclerio RM, Proud D, et al.: Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985, 76:1375–1381.
22. Fokkens WJ, Holm AF, Rijntjes E, et al.: Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990, 93:66–72.
23. Amin K, Ludviksdottir D, Janson C, et al.: Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med 2000, 162:2295–2301.
24. Svensson C, Andersson M, Greiff L, Persson CG: Nasal mucosal endorgan hyperresponsiveness. Am J Rhinol 1998, 12:37–43.
25. Powe DG, Huskisson RS, Carney AS, et al.: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001, 31:864–872.
26. Blom H, Godthelp T, Fokkens W, et al.: Mast cells, eosinphils and IgE-positive cells in the nasal mucosa of patients wiht vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngolg 1995,252(Suppl 1):S33-S39.
27. Platts-Mills TA: Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979, 122:2218–2225.
28. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ: Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000, 15:491–497.
29. Durham SR, Gould HJ, Thienes CP, et al.: Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997, 27:2899–2906.
30. Vinke JG, KleinJan A, Severijnen LW, Fokkens WJ: Passive smoking causes an ‘allergic’ cell infiltrate in the nasal mucosa of non-atopic children. Int J Pediatr Otorhinolaryngol 1999, 51:73–81.
31. Villar MT, Holgate ST: IgE, smoking and lung function. Clin Exp Allergy 1995, 25:206–209.
32. Blom HM, Severijnen LA, Van Rijswijk JB, et al.: The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998, 28:1351–1358.
33. Lundblad L, Sipila P, Farstad T, Drozdziewicz D: Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001, 121:505–509.
34. Lieberman P: Treatment update: nonallergic rhinitis. Allergy Asthma Proc 2001, 22:199–202.
35. Banov CH, Lieberman P: Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001, 86:28–35.
36. Silber G, Proud D, Warner J, et al.: In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis 1988, 137:606–612.
37. Philip G, Sanico AM, Togias A: Inflammatory cellular influx follows capsaicin nasal challenge. Am J Respir Crit Care Med 1996, 153:1222–1229.
38. Jankowski R, Philip G, Togias A, Naclerio R: Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology 1993, 31:97–100.
39. Togias A, Proud D, Kagey-Sobotka A, et al.: The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol 1987, 79:599–604.
40. Cruz AA, Togias AG, Lichtenstein LM, et al.: Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis 1991, 143:761–765.
41. Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992, 90:1045–1050. Comprehensive review on neural influences in the nasal mucosa. Ten years old, but very relevant.
42. Anggard A: Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol 1993, 113:394–396.
43. Sanico AM, Atsuta S, Proud D, Togias A: Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997, 100:632–641.
44. Baraniuk JN: Neuropeptides. Am J Rhinol 1998, 12:9–16. Neuropeptides made clear.
45. Philip G, Baroody FM, Proud D, et al.: The human nasal response to capsaicin. J Allergy Clin Immunol 1994, 94:1035–1045.
46. Stjarne P, Lundblad L, Lundberg JM, Anggard A: Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989, 96:693–701.
47. Filiaci F, Zambetti G, Ciofalo A, et al.: Local treatment of aspecific nasal hyperreactivity with capsaicin. Allergol Immunopathol (Madr) 1994, 22:264–268.
48. Rinder J, Stjarne P, Lundberg JM: Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology 1994, 32:173–178.
49. Braat JP, Fokkens WJ, Mulder PG, et al.: Forced expiration through the nose is a stimulus for NANIPER but not for controls. Rhinology 2000, 38:172–176.
50. Jaradeh SS, Smith TL, Torrico L, et al.: Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope 2000, 110:1828–1831.
51. Fernandes CM: Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol 1994, 108:569–573.
52. Malmberg H, Grahne B, Holopainen E, Binder E: Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol 1983, 8:273–276.
53. Dockhorn R, Aaronson D, Bronsky E, et al.: Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999, 82:349–359. Interesting study showing the additional effect of Ipratropium bromide on local corticosteroid spray. Does it imply that different pathofysiological mechanisms play a role at the same time?
54. Georgitis JW, Banov C, Boggs PB, et al.: Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy 1994, 24:1049–1055.
55. Wilde AD, Cook JA, Jones AS: The nasal response to isometric exercise in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol 1996, 21:84–86. New data proving a very old and more or less discarded theory on sympathetic involvement in idiopatic rhinitis
56. Wilde D, Cook JA, Jones AS: The nasal response to axillary pressure in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol 1997, 22(3):219–221.
57. Tan R, Corren J: Optimum treatment of rhinitis in the elderly. Drugs Aging 1995, 7:168–175.
58. Kirkegaard J, Mygind N, Molgaard F, et al.: Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol 1987, 79:585–590.
59. Greiff L, Andersson M, Akerlund A, et al.: Microvascular exudative hyperresponsiveness in human coronavirusinduced common cold. Thorax 1994, 49:121–127.
60. Riccio MM, Proud D: Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996, 97:1252–1263.